Log In
person
Invitae Corp
NVTAQ
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Diagnostic Tests |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
310.34M | 60.11% |
| Diagnostic Tests |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Paid for By Hospitals
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
167.51M | 32.44% |
| Diagnostic Tests |
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
38.45M | 7.45% |
| keyboard_arrow_down |
Diagnostic Tests
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
|
310.34M | 60.11% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
||
| keyboard_arrow_down |
Diagnostic Tests
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Paid for By Hospitals
|
167.51M | 32.44% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
||
| keyboard_arrow_down |
Diagnostic Tests
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
|
38.45M | 7.45% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
||